⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PRAX News
Praxis Precision Medicines, Inc. Common Stock
Remix Therapeutics Appoints Nicole Sweeny as Chief Commercial Officer
globenewswire.com
KALV
PRAX
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
PRAX
Dravet Syndrome Market Trends Indicate Sustained Growth During the Forecast Period (2026–2036), Driven by Novel Treatment Approaches | DelveInsight
globenewswire.com
BIIB
HRMY
XNCR
AZN
LLY
PFE
REGN
NVS
TSLA
TAK
GSK
JNJ
UCB
BHF
PRAX
XENE
AQST
TNDM
INCY
MRK
ABBV
BMY
AMGN
GILD
VRTX
CRSP
EDIT
NTLA
SRPT
ALNY
EXAS
TEVA
AXSM
CYTK
INSM
KODK
LPCN
MNKD
NBIX
NCLH
ONCY
ORIC
PBYI
PEGA
PLRX
PRGS
QGEN
RGNX
ROST
RYAAY
SNOW
SWKS
SYK
TGT
TRMB
TXG
ULTA
VRSK
WDC
WVE
XOM
ZBRA
ZNTL
ZTS
STOK
IONS
MOMO
BBAR
CTXR
MBIO
GNS
NEON
OVID
BHVN
Form 8-K
sec.gov
PRAX
Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2026 Financial Results
globenewswire.com
PRAX
Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2026 Financial Results
globenewswire.com
PRAX
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
PRAX
Praxis Precision Medicines to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026
globenewswire.com
PRAX
Form 8-K
sec.gov
PRAX
Praxis Precision Medicines and Remagine Labs Announce Strategic Collaboration to Develop Transdermal Ulixacaltamide for Essential Tremor
globenewswire.com
PRAX